AERI : Summary for Aerie Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets close in 4 hrs 49 mins

Aerie Pharmaceuticals, Inc. (AERI)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
39.08-1.22 (-3.04%)
As of 11:11 AM EST. Market open.
People also watch:
ITCICLVSPTCTALDRAKBA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close40.30
Open40.90
Bid39.15 x 100
Ask39.25 x 300
Day's Range39.03 - 40.90
52 Week Range10.82 - 43.40
Volume82,311
Avg. Volume1,219,693
Market Cap1.3B
Beta1.14
PE Ratio (TTM)-11.87
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is DHT Holdings Inc (DHT) About to Sink? Hedge Funds Are Fleeing
    Insider Monkey3 days ago

    Is DHT Holdings Inc (DHT) About to Sink? Hedge Funds Are Fleeing

    Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. Many hedge funds, like Paul Singer’s Elliott Management, are pretty secretive, but we can still get some insights by analyzing […]

  • Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC
    Investor's Business Daily5 days ago

    Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC

    Biotech stocks will likely close 2016 down by double digits, but 2017 is filled with catalysts, RBC analyst Adnan Butt says.

  • Business Wire5 days ago

    Aerie Pharmaceuticals to Participate in Two Investor Conferences in December

    Aerie Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that company management will participate in the following conferences in December.